miroliverELAP® for the Treatment of Acute Liver Failure: A Phase 1 Trial

Clinical trial NCT06285253 · COMPLETED

Trial details

NCT number: NCT06285253
Sponsor: Miromatrix Medical Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Liver Failure Acute Liver Injury, Drug Induced Acute on Chronic Liver Failure (ACLF)Acute Alcoholic Hepatitis

Start date: 2024-10-05
Primary completion: 2026-01-22
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.